Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Quazepam is a long-acting benzodiazepine used to manage insomnia. It was first approved in the US in 1985 and is used as a hypnotic for the treatment of insomnia.
- Mechanism
- Curator reviewed · 2 references
Like other benzodiazepines, quazepam likely exerts its effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA(A) receptors, the main inhibitory neurotransmitter receptors in the mammalian brain. GABA(A) receptors are a component of GABA-gated ionotropic chloride channels that produce inhibitory postsynaptic potentials - following activation by GABA, the channel undergoes a conformational change that allows the passage of chloride ions through the channel. The inhibitory potentials produced by GABA neurotransmission play an integral role in the suppression and control of epileptiform nerve firing such as that seen in epilepsy, which makes the GABA system a desirable target in the treatment of epilepsy.
Benzodiazepines are positive allosteric modulators of GABA(A) function. They bind to the interface between alpha (α) and gamma (γ) subunits on the receptor, commonly referred to as the benzodiazepine binding site, and modulate the receptor such that its inhibitory response to GABA binding is dramatically increased.
- Primary indication
- Quazepam is indicated for the treatment of insomnia characterized by difficulty falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.Curator reviewed · 1 structured indication
- Formula / weight
- C17H11ClF4N2S · 386.794 g/mol (avg)
- First approval
- United States, 1985
- Code names
- SCH-16134
- Brand names
- Doral
Resolves to
IKMPWMZBZSAONZ-UHFFFAOYSA-NSMILESFC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2What you can answer from here — as of September 16, 2026
Which drugs share a target with Quazepam, and which of those have an active Phase 3 trial?